For professional investors in Brazil

Insights

Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.

Accelerating innovation in the biotechnology sector may offer investors new potential growth opportunities. In a market environment where we believe investors should tread carefully, join Jennifer Nichols, Client Portfolio Manager and Matthew Bullock, EMEA Head of Portfolio Construction and Strategy as they discuss how healthcare’s unique blend of defensive characteristics and growth potential may offer immunity from the downturn.

1 minute watch

1 minute watch